JP2012531896A5 - - Google Patents

Download PDF

Info

Publication number
JP2012531896A5
JP2012531896A5 JP2012517837A JP2012517837A JP2012531896A5 JP 2012531896 A5 JP2012531896 A5 JP 2012531896A5 JP 2012517837 A JP2012517837 A JP 2012517837A JP 2012517837 A JP2012517837 A JP 2012517837A JP 2012531896 A5 JP2012531896 A5 JP 2012531896A5
Authority
JP
Japan
Prior art keywords
human
cells
mammal
functional
human mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012517837A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012531896A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/040260 external-priority patent/WO2011002727A1/en
Publication of JP2012531896A publication Critical patent/JP2012531896A/ja
Publication of JP2012531896A5 publication Critical patent/JP2012531896A5/ja
Pending legal-status Critical Current

Links

JP2012517837A 2009-06-29 2010-06-28 ヒト化非ヒト哺乳動物を製造する方法 Pending JP2012531896A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22143809P 2009-06-29 2009-06-29
US61/221,438 2009-06-29
PCT/US2010/040260 WO2011002727A1 (en) 2009-06-29 2010-06-28 Methods of producing humanized non-human mammals

Publications (2)

Publication Number Publication Date
JP2012531896A JP2012531896A (ja) 2012-12-13
JP2012531896A5 true JP2012531896A5 (https=) 2013-08-15

Family

ID=43411395

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012517837A Pending JP2012531896A (ja) 2009-06-29 2010-06-28 ヒト化非ヒト哺乳動物を製造する方法

Country Status (6)

Country Link
US (1) US20120157667A1 (https=)
EP (1) EP2449094A4 (https=)
JP (1) JP2012531896A (https=)
CN (1) CN102725400A (https=)
SG (2) SG176118A1 (https=)
WO (1) WO2011002727A1 (https=)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT2485583T (pt) 2009-10-06 2016-09-22 Univ Yale Ratinhos geneticamente modificados e enxerto
MX350385B (es) 2011-02-15 2017-09-04 Regeneron Pharma Ratones de m-csf humanizada.
WO2013086019A1 (en) * 2011-12-06 2013-06-13 Massachusetts Institute Of Technology Use of humanized mice to determine toxicity
CN103387955B (zh) * 2012-05-10 2015-04-29 上海南方模式生物科技发展有限公司 非人哺乳动物b淋巴细胞缺陷动物模型的制备方法及其用途
WO2014039733A1 (en) * 2012-09-05 2014-03-13 University Of Southern California Methods and compositions for detecting, imaging, and treating small cell lung cancer utilizing post-translationally modified residues and higher molecular weight antigenic complexes in proteins
IN2015DN02032A (https=) * 2012-09-07 2015-08-14 Univ Yale
CA2887706C (en) 2012-11-05 2022-08-02 Regeneron Pharmaceuticals Genetically modified non-human animals and methods of use thereof
WO2014121840A1 (en) * 2013-02-07 2014-08-14 Medizinische Hochschule Hannover Induced dendritic cells and uses thereof
US20160135437A1 (en) * 2013-06-05 2016-05-19 Agency For Science, Technology And Research Humanized mouse model for study of bona fide hepatitis virus infection and use thereof
NO2785538T3 (https=) * 2014-05-07 2018-08-04
SG10202002187WA (en) * 2014-05-19 2020-04-29 Regeneron Pharma Genetically modified non-human animals expressing human epo
KR102658190B1 (ko) 2015-04-13 2024-04-17 리제너론 파마슈티칼스 인코포레이티드 인간화된 sirpa-il15 녹인 마우스 및 이의 이용 방법
JP6654001B2 (ja) * 2015-05-27 2020-02-26 公益財団法人実験動物中央研究所 ヒトil−15分泌免疫不全マウス
JP2019508014A (ja) * 2015-11-30 2019-03-28 エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト 免疫不全の非ヒト宿主におけるヒトマクロファージの生成
CN111315881B (zh) * 2017-11-17 2023-10-10 国立大学法人筑波大学 非人类动物及其生产方法
CN111304248B (zh) 2018-12-25 2021-08-24 百奥赛图江苏基因生物技术有限公司 人源化细胞因子il15基因改造非人动物的构建方法及应用
CN111172190B (zh) * 2018-12-25 2021-07-30 百奥赛图江苏基因生物技术有限公司 人源化细胞因子csf2基因改造非人动物的构建方法及应用
US11419317B2 (en) 2019-01-28 2022-08-23 Central Institute For Experimental Animals Non-human animal having human IL-34 and use Thereof
US12378574B2 (en) 2019-02-13 2025-08-05 The Jackson Laboratory Transgenic mouse models supporting innate immune function
CN113614238B (zh) * 2019-03-28 2024-10-22 公益财团法人实中研 免疫缺陷小鼠
CN111485001A (zh) * 2020-04-14 2020-08-04 澎立生物医药技术(上海)有限公司 具有nk细胞及adcc能力的人源化免疫系统小鼠的构建方法
JP2023533979A (ja) * 2020-07-08 2023-08-07 ザ ジャクソン ラボラトリー ヒト自然免疫機能を支えるトランスジェニックマウスモデル
CN112042597B (zh) * 2020-07-22 2022-04-29 南京普恩瑞生物科技有限公司 一种双人源化肿瘤异种移植模型的构建方法
CN114853871B (zh) * 2021-04-20 2024-04-05 百奥赛图(北京)医药科技股份有限公司 Csf1和/或csf1r基因人源化的非人动物及其构建方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639939A (en) * 1987-12-23 1997-06-17 The Board Of Trustees For The Leland Stanford Junior University Chimeric immunocompromised mammal comprosing vascularized fetal organ tissue
ES2071620T3 (es) * 1987-12-23 1995-07-01 Univ Leland Stanford Junior Mamiferos inmunodeficientes quimericos y su utilizacion.
AU1402495A (en) * 1993-12-17 1995-07-03 Systemix, Inc. Use of macrophage depleting agents for prolonging the survival of non-autologus hematopoietic cell transplants and animal model assay systems
US6015554A (en) * 1995-06-07 2000-01-18 Systemix, Inc. Method of reconstituting human lymphoid and dendritic cells
US6060643A (en) * 1995-08-04 2000-05-09 Emory University Mouse model with human immune system
US20070021364A1 (en) * 1995-12-13 2007-01-25 Hans Herweijer Methods for genetic immunization
AU4214799A (en) * 1998-05-28 1999-12-13 St. Jude Children's Research Hospital Expansion of hematopoietic stem cells transduced with mdr-1 and methods of use thereof
CA2330208A1 (en) * 1998-05-29 1999-12-02 Thomas Jefferson University Compositions and methods for use in affecting hematopoietic stem cell populations in mammals
AU2003256280A1 (en) * 2002-06-24 2004-01-06 Genzyme Corporation Methods of delivering gene therapy agents
GB0406728D0 (en) * 2004-03-25 2004-04-28 Hydrodynamic Gene Delivery Ltd Gene therapy
CN105168250B (zh) * 2004-10-25 2019-02-05 塞勒兰特治疗公司 增殖骨髓细胞群体的方法及其应用
KR102651433B1 (ko) * 2006-04-14 2024-03-25 아스텔라스 인스티튜트 포 리제너러티브 메디슨 혈관 콜로니 형성 세포
EP2134852A4 (en) * 2007-03-13 2010-04-28 Nat Jewish Health PROCESS FOR THE PRODUCTION OF ANTIBODIES
US20090215875A1 (en) * 2008-02-25 2009-08-27 Deneault Eric Methods and kits for expanding hematopoietic stem cells
WO2010115115A1 (en) * 2009-04-03 2010-10-07 Inserm ( Institut National De La Sante Et De La Recherche) Dendritic cell-boosted humanized immune system mice
DK2448967T3 (en) * 2009-06-29 2015-07-20 Ilya B Leskov NON-HUMAN MAMMALS MODEL OF CANCER human hematopoietic
PT2485583T (pt) * 2009-10-06 2016-09-22 Univ Yale Ratinhos geneticamente modificados e enxerto

Similar Documents

Publication Publication Date Title
JP2012531896A5 (https=)
Martinov et al. Building the next generation of humanized hemato-lymphoid system mice
De La Rochere et al. Humanized mice for the study of immuno-oncology
Wege Humanized mouse models for the preclinical assessment of cancer immunotherapy
AU2018202976B2 (en) Polyclonal gamma delta t cells for immunotherapy
Calmeiro et al. Dendritic cell vaccines for cancer immunotherapy: the role of human conventional type 1 dendritic cells
Zouali et al. Marginal zone B-cells, a gatekeeper of innate immunity
Cho et al. A new mechanism for the aging of hematopoietic stem cells: aging changes the clonal composition of the stem cell compartment but not individual stem cells
Billerbeck et al. Development of human CD4+ FoxP3+ regulatory T cells in human stem cell factor–, granulocyte-macrophage colony-stimulating factor–, and interleukin-3–expressing NOD-SCID IL2Rγnull humanized mice
Hara et al. Identification of podocalyxin-like protein 1 as a novel cell surface marker for hemangioblasts in the murine aorta-gonad-mesonephros region
ES2700852T3 (es) Ratones modificados genéticamente e injerto
Jin et al. Development of humanized mouse with patient‐derived xenografts for cancer immunotherapy studies: a comprehensive review
US20120157667A1 (en) Methods Of Producing Humanized Non-Human Mammals
IL299249B1 (en) Genetically modified immune cells that include adapted shrna-microRNA (shrnamir)
Salguero et al. Dendritic cell–mediated immune humanization of mice: implications for allogeneic and xenogeneic stem cell transplantation
JP2019536457A5 (https=)
JP2015534819A5 (https=)
O'Connell et al. Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations
EP4251177A2 (en) Antigen specific t cells and methods of making and using same
US8815543B2 (en) Methods of producing antigen-specific B cell populations in the presence of CD40:CD40L, BAFF:BAFF receptor and Fas:FasL stimulation
Ren et al. Translational models in glioma immunotherapy research
Eguren-Santamaria et al. Preclinical ex vivo and in vivo models to study immunotherapy agents and their combinations as predictive tools toward the clinic
Akkina Humanized mice for studying human immune responses and generating human monoclonal antibodies
Mangolini et al. Highly potent novel multi-armoured IL13Rα2 CAR-T subverts the immunosuppressive microenvironment of Glioblastoma
DOYLE et al. The CD4+ T‐cell response to protein immunization is independent of accompanying IFN‐γ‐producing CD8+ T cells